Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
Akl EA, Gunukula S, Barba M, Yosuico VE, van Doormaal FF, Kuipers S, Middeldorp S, Dickinson HO, Bryant A, Schünemann H. Akl EA, et al. Among authors: middeldorp s. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006652. doi: 10.1002/14651858.CD006652.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006652. doi: 10.1002/14651858.CD006652.pub3 PMID: 21249680 Updated. Review.
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation.
Akl EA, van Doormaal FF, Barba M, Kamath G, Kim SY, Kuipers S, Middeldorp S, Yosuico V, Dickinson HO, Schünemann HJ. Akl EA, et al. Among authors: middeldorp s. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006652. doi: 10.1002/14651858.CD006652. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006652. doi: 10.1002/14651858.CD006652.pub2 PMID: 17636846 Updated. Review.
Development in anticoagulant therapy.
van Doormaal FF, Büller HR, Middeldorp S. van Doormaal FF, et al. Among authors: middeldorp s. Crit Rev Oncol Hematol. 2008 May;66(2):145-54. doi: 10.1016/j.critrevonc.2007.09.009. Epub 2007 Nov 26. Crit Rev Oncol Hematol. 2008. PMID: 18032061 Review.
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
Akl EA, Gunukula S, Barba M, Yosuico VE, van Doormaal FF, Kuipers S, Middeldorp S, Dickinson HO, Bryant A, Schünemann H. Akl EA, et al. Among authors: middeldorp s. Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006652. doi: 10.1002/14651858.CD006652.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2014 Dec 10;(12):CD006652. doi: 10.1002/14651858.CD006652.pub4 PMID: 21491396 Updated. Review.
Parenteral anticoagulation in ambulatory patients with cancer.
Akl EA, Kahale LA, Ballout RA, Barba M, Yosuico VE, van Doormaal FF, Middeldorp S, Bryant A, Schünemann H. Akl EA, et al. Among authors: middeldorp s. Cochrane Database Syst Rev. 2014 Dec 10;(12):CD006652. doi: 10.1002/14651858.CD006652.pub4. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Sep 11;9:CD006652. doi: 10.1002/14651858.CD006652.pub5 PMID: 25491949 Updated. Review.
Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences.
Wiercioch W, Nieuwlaat R, Akl EA, Kunkle R, Alexander KE, Cuker A, Rajasekhar A, Alonso-Coello P, Anderson DR, Bates SM, Cushman M, Dahm P, Guyatt G, Iorio A, Lim W, Lyman GH, Middeldorp S, Monagle P, Mustafa RA, Neumann I, Ortel TL, Rochwerg B, Santesso N, Vesely SK, Witt DM, Schünemann HJ. Wiercioch W, et al. Among authors: middeldorp s. Blood Adv. 2020 May 26;4(10):2351-2365. doi: 10.1182/bloodadvances.2020001768. Blood Adv. 2020. PMID: 32453843 Free PMC article.
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S; Highlow Block writing committee; Highlow Investigators. Bistervels IM, et al. Among authors: middeldorp s. Lancet. 2022 Nov 19;400(10365):1777-1787. doi: 10.1016/S0140-6736(22)02128-6. Epub 2022 Oct 28. Lancet. 2022. PMID: 36354038 Clinical Trial.
475 results